Featured,Spotlight Stock,Trends & Articles Love Pharma Updates Terms for Acquisition of Microdoz Therapy By Dennis Mutua March 07, 2022 New age pharma/nutraceutical company specializing on disruptive technologies which target mental, sexual health and psychedelics markets Love Pharma Co. (CSE: LUV) (FSE: G1Q0) has updates the terms and conditions details concernin...
Featured,Spotlight Stock,Trends & Articles Field Trip Health Enters Into a Partnership With Cerebral to Provide End-to-End Mental Health Care By Dennis Mutua March 04, 2022 Biotechnology company focusing on development and delivery of technology-enabled psychedelic therapies Field Trip Health Ltd. (NASDAQ: FTRP) (TSX: FTRP) has entered into a partnership with Cerebral to provide personalized end-to-e...
Featured,Spotlight Stock,Trends & Articles MindMed Releases Study Publication Showing Effects of LCD and Psilocybin on Health Participants By Dennis Mutua March 03, 2022 Biotechnology company developing psychedelic-inspired medicines and therapies to treat addiction and mental wellness Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) announced having released the publication of a study that compares ...
Spotlight Stock,Trends & Articles Eversio Wellness Completes Development of Standardized Natural Psilocybin Products By Dennis Mutua March 02, 2022 Mushroom wellness company delivering organic mushroom extracts, vegan and gluten-free in Canada and the U.S Eversio Wellness Ltd announced having successfully developed four products of various dosage which have been third party l...
Featured,Spotlight Stock,Trends & Articles HAVN Life Granted Purchase Order for Controlled Substance Sale to Revive Therapeutics By Dennis Mutua February 28, 2022 Biotechnology company focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi HAVN Life Sciences Inc. (CSE: HAVN) (OTCMKTS: HAVLF) announced having secured a purchase order for natura...
Featured,Spotlight Stock,Trends & Articles Mydecine Approved by the FDA and DEA to Cultivate Psilocybin Mushrooms in the United States By Dennis Mutua February 24, 2022 Biotechnology company developing innovative first and second generation novel compounds therapeutics to treat addiction and mental health Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) has been granted approval by the U.S Foo...
Featured,Spotlight Stock,Trends & Articles Optimi Health Launches E-Commerce Platform Comprising All Natural Functional Mushroom Supplements By Dennis Mutua February 23, 2022 Biotechnology company developing integrated functional mushroom brand which focuses on health and wellness Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) has officially launched its line of functional mushroom supplements to consu...
Spotlight Stock,Trends & Articles Awakn Submits Patent Application For a New Class of Entactogen Molecules By Dennis Mutua February 22, 2022 Biotechnology company running clinical operations, developing and delivering psychedelics to treat addictions and mental conditions Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) has submitted a patent application for a new ...